CA15.3, CEA and LDH in dogs with malignant mammary tumors.
about
Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.Prevalence of Glomerulopathies in Canine Mammary CarcinomaPrognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.Current biomarkers of canine mammary tumorsTranscriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers
P2860
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@en
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@nl
type
label
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@en
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@nl
prefLabel
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@en
CA15.3, CEA and LDH in dogs with malignant mammary tumors.
@nl
P2093
P2860
P1476
CA15.3, CEA and LDH in dogs with malignant mammary tumors
@en
P2093
A F D Vieira da Costa
G D Cassali
G E Lavalle
J C Melgaço de Faria
J E Guimarães
L C Campos
L P de Sousa
É M L Rabelo
P2860
P304
P356
10.1111/J.1939-1676.2012.01014.X
P577
2012-11-01T00:00:00Z